Browsing by Author Grob, Jean Jacques

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 7 of 7
Issue DateTitleAuthor(s)Citation
2014Combined BRAF and MEK inhibition versus BRAF inhibition alone in melanomaLong, Georgina; Chiarion-Sileni, Vanna; De Braud, Filippo; et al, Various; Garbe, Claus; Gogas, Helen; Grob, Jean Jacques; Hauschild, Axel; Jouary, Thomas; Larkin, James; Levchenko, Evgeny; Stroyakovskiy, Daniil; Central Clinical School: The Sydney Cancer CentreCombined BRAF and MEK inhibition versus BRAF inhibition alone in melanoma, The New England Journal of Medicine, vol.371, 20, 2014,pp 1877-1888
2015Comparison of dabrafenib and trametinib combination therapy with vemurafenib monotherapy on health-related quality of life in patients with unresectable or metastatic cutaneous BRAF Val600-mutation-positive melanoma (COMBI-v): results of a phase 3, open-label, randomised trialLong, Georgina; Amonkar, Mayur M; Drucis, Kamil; Dummer, R; et al, Various; Grange, Florent; Grob, Jean Jacques; Karaszewska, Boguslawa; Mackiewicz, Andrzej; Schachter, Jacob; Stroyakovskiy, Daniil; Central Clinical School: The Sydney Cancer CentreComparison of dabrafenib and trametinib combination therapy with vemurafenib monotherapy on health-related quality of life in patients with unresectable or metastatic cutaneous BRAF Val600-mutation-positive melanoma (COMBI-v): results of a phase 3, open-label, randomised trial, The Lancet Oncology, vol.16, 13, 2015,pp 1389-1398
2013Final Results of Phase III SYMMETRY Study: Randomized, Double-Blind Trial of Elesclomol Plus Paclitaxel Versus Paclitaxel Alone As Treatment for Chemotherapy-Naive Patients With Advanced MelanomaKefford, Richard (Rick); Chiarion-Sileni, Vanna; Eggermon, Alexander; et al, Various; Grob, Jean Jacques; Mackiewicz, Jacek; Mortier, Laurent; O'Day, Steven; Robert, Caroline; Schachter, Jacob; Testori, Alessandro; Western Clinical School: Westmead Millennium InstituteFinal Results of Phase III SYMMETRY Study: Randomized, Double-Blind Trial of Elesclomol Plus Paclitaxel Versus Paclitaxel Alone As Treatment for Chemotherapy-Naive Patients With Advanced Melanoma, Journal of Clinical Oncology, vol.31, 9, 2013,pp 1211-1218
2017Nivolumab for Patients With Advanced Melanoma Treated Beyond Progression Analysis of 2 Phase 3 Clinical TrialsLong, Georgina; Atkinson, V; Dummer, R; et al, Various; Grob, Jean Jacques; Larkin, James; Márquez-Rodas, Ivan; McNeil, Catriona M.; Robert, Caroline; Schadendorf, Dirk; Schmidt, Henrik; Weber, Jeffrey; Northern Clinical School: MedicineNivolumab for Patients With Advanced Melanoma Treated Beyond Progression Analysis of 2 Phase 3 Clinical Trials, JAMA Oncology, vol.3, 11, 2017,pp 1511-1519
2017Pembrolizumab versus ipilimumab for advanced melanoma: final overall survival results of a multicentre, randomised, open-label phase 3 study (KEYNOTE-006)Carlino, Matteo; Long, Georgina; Arance, A; Daud, Adil; et al, Various; Grob, Jean Jacques; Larkin, James; Lotem, Michal; McNeil, Catriona M.; Mortier, Laurent; Ribas, Antoni; Schachter, Jacob; Western Clinical School: Medicine (Westmead); Northern Clinical School: MedicinePembrolizumab versus ipilimumab for advanced melanoma: final overall survival results of a multicentre, randomised, open-label phase 3 study (KEYNOTE-006), The Lancet, vol.390, 10105, 2017,pp 1853-1862
2015Pembrolizumab versus ipilimumab in advanced melanomaCarlino, Matteo; Long, Georgina; Arance, Ana; Daud, Adil; et al, Various; Grob, Jean Jacques; Larkin, James; Lorigan, Paul; Lotem, Michal; McNeil, Catriona; Mortier, Laurent; Neyns, Bart; Robert, Caroline; Schachter, Jacob; Western Clinical School: Medicine (Westmead); Central Clinical School: The Sydney Cancer CentrePembrolizumab versus ipilimumab in advanced melanoma, The New England Journal of Medicine, vol.372, 26, 2015,pp 2521-2532
2015A randomized, controlled phase III trial of nab-Paclitaxel versus dacarbazine in chemotherapy-naïve patients with metastatic melanomaKefford, Richard (Rick); Agarwala, Sanjiv; Bhatia, S.; Brachmann, C.; Brown, Michael P.; Clawson, A.; Conry, Robert; Del Vecchio, M.; Elias, I.; Ernst, S.; Grob, Jean Jacques; Gutzmer, R.; Hauschild, A; Haydon, A.; Hersh, Evan M.; Homsi, J.; Karnoub, M; Kendra, K.; Li, M.; Loquai, C.; Rebscgler, M. F.; Robert, Caroline; Testori, Alessandro; Western Clinical School: Westmead Institute for Medical ResA randomized, controlled phase III trial of nab-Paclitaxel versus dacarbazine in chemotherapy-naïve patients with metastatic melanoma, Annals of Oncology, vol.26, 11, 2015,pp 2267-2274